162 related articles for article (PubMed ID: 35022660)
1. NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer.
Qian J; Huang C; Zhu Z; He Y; Wang Y; Feng N; He S; Li X; Zhou L; Zhang C; Gong Y
Carcinogenesis; 2022 Jun; 43(5):457-468. PubMed ID: 35022660
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation.
Wang X; Li Y; Fang Z; Li Y
Bioengineered; 2021 Dec; 12(2):12204-12214. PubMed ID: 34783304
[TBL] [Abstract][Full Text] [Related]
3. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
Yu MM; Feng YH; Zheng L; Zhang J; Luo GH
World J Gastroenterol; 2019 Mar; 25(10):1210-1223. PubMed ID: 30886504
[TBL] [Abstract][Full Text] [Related]
4. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
5. TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation.
Chen Z; He S; Zhan Y; He A; Fang D; Gong Y; Li X; Zhou L
EBioMedicine; 2019 Sep; 47():208-220. PubMed ID: 31420300
[TBL] [Abstract][Full Text] [Related]
6. PODNL1 promotes cell migration and regulates the epithelial/mesenchymal transition process in bladder cancer.
Liu X; He Y; Tong Y; Huang Q; Shang H; Chen Z; Tang K
Biochem Biophys Res Commun; 2022 Sep; 620():165-172. PubMed ID: 35797736
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms.
Zeng S; Liu A; Dai L; Yu X; Zhang Z; Xiong Q; Yang J; Liu F; Xu J; Xue Y; Sun Y; Xu C
BMC Cancer; 2019 Jun; 19(1):604. PubMed ID: 31216997
[TBL] [Abstract][Full Text] [Related]
8. Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.
Martins-Lima C; Miranda-Gonçalves V; Lobo J; Constâncio V; Leite-Silva P; Guimarães-Teixeira C; Monteiro-Reis S; Sequeira JP; Cantante M; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
Cell Oncol (Dordr); 2022 Feb; 45(1):135-149. PubMed ID: 35064910
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression.
Liu B; Pan S; Liu J; Kong C
Gene; 2021 Apr; 775():145451. PubMed ID: 33482279
[TBL] [Abstract][Full Text] [Related]
10. LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28/TGF-β/Smad pathway.
Shi H; Xie J; Wang K; Li W; Yin L; Wang G; Wu Z; Ni J; Mao W; Guo C; Peng B
Cell Signal; 2021 May; 81():109932. PubMed ID: 33516780
[TBL] [Abstract][Full Text] [Related]
11. Small Cajal Body-Specific RNA12 Promotes Carcinogenesis through Modulating Extracellular Matrix Signaling in Bladder Cancer.
Lu Q; Wang J; Tao Y; Zhong J; Zhang Z; Feng C; Wang X; Li T; He R; Wang Q; Xie Y
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339238
[No Abstract] [Full Text] [Related]
12. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylated ITGA8 Facilitate Bladder Cancer Cell Proliferation and Metastasis.
Ma X; Zhang L; Liu L; Ruan D; Wang C
Appl Biochem Biotechnol; 2024 Jan; 196(1):245-260. PubMed ID: 37119505
[TBL] [Abstract][Full Text] [Related]
14. NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the proteasome-dependent degradation of ISGylated p53.
Ren Y; Yang J; Ding Z; Zheng M; Qiu L; Tang A; Huang D
Cancer Sci; 2023 Sep; 114(9):3523-3536. PubMed ID: 37350063
[TBL] [Abstract][Full Text] [Related]
15. A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression.
Chakravarthi BVSK; Rodriguez Pena MDC; Agarwal S; Chandrashekar DS; Hodigere Balasubramanya SA; Jabboure FJ; Matoso A; Bivalacqua TJ; Rezaei K; Chaux A; Grizzle WE; Sonpavde G; Gordetsky J; Netto GJ; Varambally S
Neoplasia; 2018 Sep; 20(9):894-904. PubMed ID: 30121007
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA hsa_circ_0017247 acts as an oncogene in bladder cancer by inducing Wnt/β-catenin signaling pathway.
Han CT; Bao QY; Cheng SJ; Liu M; Qian HN; Li D
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1081-1087. PubMed ID: 32096177
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
18. Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition.
Monteiro-Reis S; Miranda-Gonçalves V; Guimarães-Teixeira C; Martins-Lima C; Lobo J; Montezuma D; Dias PC; Neyret-Kahn H; Bernard-Pierrot I; Henrique R; Jerónimo C
Int J Biol Sci; 2023; 19(1):1-12. PubMed ID: 36594099
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance and immunoinfiltration analysis of genes associated with epithelial-mesenchymal transition and energy metabolism in bladder urothelial carcinoma.
Qiu Y; Ye W; Wang C; Zang J
Aging (Albany NY); 2023 Nov; 15(22):13312-13328. PubMed ID: 38015710
[TBL] [Abstract][Full Text] [Related]
20. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]